Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(80%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
20%
Ph phase_1
1
20%
Ph phase_2
3
60%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

5

all time

Status Distribution
Active(4)
Completed(1)

Detailed Status

Recruiting4
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 23 (60.0%)
Phase 31 (20.0%)

Trials by Status

completed120%
recruiting480%

Recent Activity

4 active trials
Showing 5 of 5
recruitingphase_2

Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria

NCT07378527
completedphase_1

Phase I Study of ICP-332 in Healthy Subjects

NCT06530966
recruitingphase_2

Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis

NCT07251998
recruitingphase_3

ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis

NCT06775860
recruitingphase_2

ICP-332 in Subjects With Non-segmental Vitiligo

NCT07047612

Clinical Trials (5)

Showing 5 of 5 trials
NCT07378527Phase 2

Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria

Recruiting
NCT06530966Phase 1

Phase I Study of ICP-332 in Healthy Subjects

Completed
NCT07251998Phase 2

Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis

Recruiting
NCT06775860Phase 3

ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis

Recruiting
NCT07047612Phase 2

ICP-332 in Subjects With Non-segmental Vitiligo

Recruiting

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5